Overall Fundamental outlook

Business Operations:

Sector: Basic Materials
Industry: Specialty Chemicals

Balaji Amines Limited engages in the manufacture and sale of methylamines, ethylamines, and derivatives of specialty chemicals and pharma excipients in India. The company operates in two segments, Chemicals and Hotel. It offers monomethylamine, dimethylamine, trimethylamine, monoethylamine, diethylamine, triethylamine, and dimethyl and diethyl amino ethanol; and specialty chemicals, including N-methyl pyrrolidone, morpholine, 2-pyrrolidone, N-ethyl-2-pyrrolidone, gamma-butyrolactone, dimethylformamide, acetonitrile, dimethylcarbonate, propylene glycol, and propylene carbonate. The company also provides derivatives comprising di-methyl acetamide, di-methyl amine hydrochloride, tri-methyl amine hydrochloride, di-ethyl amine hydrochloride, tri-ethyl amine hydrochloride, di-methyl urea, choline chloride, mono-ethyl amine hydrochloride, and benzyl tri ethyl ammonium chloride; and pharma excipients, such as poly vinyl pyrrolidone. In addition, it operates Balaji Sarovar Premiere, a hotel in Solapur, Maharashtra, as well as engages in the provision of hotel, restaurant, and hospitality services. The company serves pharmaceutical, agrochemical, paint and resin, animal feed, oil and gas, rubber cleaning chemical, dye and textile, pesticides and insecticides, water treatment chemical, optical brighteners, corrosion inhabitations, cosmetics, explosives, and foundry chemicals industries. It also exports its products to the United States, the United Kingdom, Argentina, Latin America, Canada, Israel, Australia, Bangladesh, Germany, Italy, Egypt, South Africa, and internationally. Balaji Amines Limited was incorporated in 1988 and is headquartered in Solapur, India.

Revenue projections:

Revenue projections for BALAMINES
Revenue projections for BALAMINES

BALAMINES's revenue projections indicate a decrease from the prior year, which may make investors hesitant. A revenue decline could harm the company's bottom line, prompting investors to be more careful, as lower earnings often signal potential issues with profitability and future performance.

Financial Ratios:

currentRatio 0.000000
forwardPE 20.569586
debtToEquity 0.546000
earningsGrowth -0.122000
revenueGrowth -0.069000
grossMargins 0.426780
operatingMargins 0.113640
trailingEps 46.940000
forwardEps 0.000000

BALAMINES's Forward PE is at a healthy level, indicating that the stock price is well-positioned relative to its earnings. With the stock not being overvalued, there remains room for future growth, suggesting a balanced opportunity for investors seeking potential upside.
Balaji Amines Limited's low earnings and revenue growth point to a likely decrease in profits. This suggests that the company is facing financial difficulties and may struggle to maintain its current level of profitability.
BALAMINES's negative gross and operating margins point to financial difficulties, as the company is unable to generate profit from its core operations or production. This could signal broader problems in cost management or declining sales.

Price projections:

Price projections for BALAMINES
Price projections for BALAMINES

The gradual downward revision of BALAMINES's price projections signals decreasing confidence in the company's future performance. Analysts are adjusting their expectations, reflecting uncertainty about BALAMINES's growth potential.

Recommendation changes over time:

Recommendations trend for BALAMINES
Recommendations trend for BALAMINES


A recent buy bias from analysts toward Balaji Amines Limited may inspire confidence in investors, who could view the stock as a promising investment. This positive sentiment suggests that Balaji Amines Limited might be an appealing option for those looking to grow their wealth through stock market investments.